Abstract: According to the invention there is provided pemirolast, or a pharmaceutically acceptable salt thereof, for use in the therapeutic treatment of asthma, such as an acute asthma attack. Suitable lower doses of pemirolast are least about 110 mg per day.
Type:
Grant
Filed:
February 4, 2016
Date of Patent:
November 15, 2016
Assignee:
RSPR Pharma AB
Inventors:
Johan Raud, Carl-Johan Dalsgaard, Jesper Säfholm
Abstract: According to the invention there is provided a method for the treatment of airway hyperresponsiveness, which method comprises the administration of pemirolast, or a pharmaceutically acceptable salt thereof, to a patient in need of such treatment. Suitable lower doses of pemirolast are least about 110 mg per day.
Type:
Grant
Filed:
November 24, 2015
Date of Patent:
August 16, 2016
Assignee:
RSPR Pharma AB
Inventors:
Johan Raud, Carl-Johan Dalsgaard, Göran Tornling